Drug Type TIL therapy |
Synonyms- |
Target- |
Action- |
Mechanism Immunologic cytotoxicity, Lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Melanoma, Cutaneous Malignant | Phase 1 | - | 01 Mar 2026 | |
| Liver metastases | Phase 1 | - | 31 Dec 2023 | |
| Metastatic melanoma | Phase 1 | - | 31 Dec 2023 | |
| Uveal Melanoma | Phase 1 | - | 31 Dec 2023 |





